Cardarine

Cardarine, also known as GW-501516 or Endurobol, is a research chemical that gained attention for its potential investigational properties related to endurance, fat metabolism, and muscle protection. It is classified as a peroxisome proliferator-activated receptor delta (PPAR-delta) agonist. This means it binds to and activates the PPAR-delta receptor, which is found in many tissues throughout the body, including muscle, liver, and adipose tissue. Activation of this receptor plays a role in cellular processes involved in energy metabolism. Initially developed in the 1990s as a potential treatment for metabolic diseases like obesity, diabetes, and cardiovascular diseases, Cardarine's development was halted in 2007 due to safety concerns identified in animal studies. Despite its discontinuation in pharmaceutical development, Cardarine continues to be used in research settings and has been, at times, illicitly marketed and used in sports for its purported performance-enhancing effects. It is important to understand that Cardarine is not approved for human use as a drug or dietary supplement by regulatory bodies such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA). Its use outside of a controlled research environment carries significant risks.